Company intelligence / Profile preview

Smartlens

Mountain View, California, United Statessmartlens.health ↗

Ownership: Private
Development stage: Preclinical

Overview

Smartlens has demonstrated strong clinical results for its miLens™, a non-invasive, electronics-free soft contact lens that uses microfluidics to monitor intraocular pressure. Clinical studies showed high correlation with the gold standard Goldmann applanation tonometry and high patient comfort. The company is advancing toward regulatory clearance and commercialization in 2024.

Therapeutic areas: Ophthalmology
Modalities: DeviceMicrofluidic deviceAI-powered diagnostics
Industry: Physiological Monitoring

Partnerships

Stanford University (exclusive license holder of foundational IP)

Beyond the preview

Go deeper on Smartlens.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Smartlens.

Explore the full profile